CA2185663A1 - Preparation d'un compose polysaccharidique d25 delipide et purifie et composition injectable en comportant - Google Patents

Preparation d'un compose polysaccharidique d25 delipide et purifie et composition injectable en comportant

Info

Publication number
CA2185663A1
CA2185663A1 CA002185663A CA2185663A CA2185663A1 CA 2185663 A1 CA2185663 A1 CA 2185663A1 CA 002185663 A CA002185663 A CA 002185663A CA 2185663 A CA2185663 A CA 2185663A CA 2185663 A1 CA2185663 A1 CA 2185663A1
Authority
CA
Canada
Prior art keywords
compound
preparation
delipidated
purified
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002185663A
Other languages
English (en)
French (fr)
Inventor
Hans Binz
Jacques Durand
Claude-Alain Cudennec
Gerard Normier
Alain Le Pape
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2185663A1 publication Critical patent/CA2185663A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002185663A 1994-03-16 1995-03-15 Preparation d'un compose polysaccharidique d25 delipide et purifie et composition injectable en comportant Abandoned CA2185663A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9403072A FR2717483B1 (fr) 1994-03-16 1994-03-16 Préparation d'un composé polysaccharidique D25 délipidé et purifié et composition injectable en comportant.
FR94/03072 1994-03-16

Publications (1)

Publication Number Publication Date
CA2185663A1 true CA2185663A1 (fr) 1995-09-21

Family

ID=9461103

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002185663A Abandoned CA2185663A1 (fr) 1994-03-16 1995-03-15 Preparation d'un compose polysaccharidique d25 delipide et purifie et composition injectable en comportant

Country Status (6)

Country Link
EP (1) EP0750640A1 (fi)
JP (1) JPH09512842A (fi)
AU (1) AU2075595A (fi)
CA (1) CA2185663A1 (fi)
FR (1) FR2717483B1 (fi)
WO (1) WO1995025128A1 (fi)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
US4054645A (en) * 1976-08-24 1977-10-18 Minnesota Mining And Manufacturing Company Radiodiagnostic complexes employing fluorine-containing tin reducing agents
US4755381A (en) * 1986-03-27 1988-07-05 Swiss Serum And Vaccine Institute Berne Klebsiella capsular polysaccharide vaccine
FR2659351B1 (fr) * 1990-03-08 1994-12-02 Pf Medicament Compose polysaccharidique delipide, procede de preparation, compositions en comprenant.

Also Published As

Publication number Publication date
JPH09512842A (ja) 1997-12-22
AU2075595A (en) 1995-10-03
FR2717483B1 (fr) 1996-06-07
FR2717483A1 (fr) 1995-09-22
WO1995025128A1 (fr) 1995-09-21
EP0750640A1 (fr) 1997-01-02

Similar Documents

Publication Publication Date Title
Etzler et al. Differential localization of cell surface and secretory components in rat intestinal epithelium by use of lectins
EP0419387B1 (fr) Nouveaux dérivés hydrophiles, application au diagnostic et à la thérapeutique, kits diagnostiques ou thérapeutiques et réactifs immunologiques
FR2562421A1 (fr) Perfectionnements a la therapie par l'interleukine
FR2682388A1 (fr) Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
FR2522967A1 (fr) Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
JP2002104993A (ja) 抗腫瘍ワクチン
EP0241376A1 (fr) Nouveaux liposomes à base de phosphatidylinositolmannosides, et compositions pharmaceutiques les contenant
JP2003533555A (ja) 葉酸−多糖複合体、その製造方法およびそれを活性成分として含む医薬組成物
EP0446143B1 (fr) Composé polysaccharidique délipidé, procédé de préparation, compositions en comprenant
CA2185663A1 (fr) Preparation d'un compose polysaccharidique d25 delipide et purifie et composition injectable en comportant
CA2954740C (en) Sulfated-glycolipids as adjuvants for vaccines
CN108159401B (zh) Apelin脂质体及其制备方法
EP2429658B1 (fr) Procédé pour adjuver le lipopolysaccharide (LPS) des bactéries à gram-négatif
EP0387154B1 (fr) Compositions aérosols destinées à l'imagerie, au diagnostic et à la thérapie ciblée de foyers inflammatoires et tumoraux
EP0787796A1 (fr) Epitopes protecteurs de l'adényl cyclase-hémolysine (AC-Hly). leur application au traitement ou à la prévention des infections par Bordetella
FR2672496A1 (fr) Compositions a base de substances hydrophobes, solubilisables dans un solvant aqueux, leur procede d'obtention, et leurs utilisations notamment dans le domaine pharmaceutique.
KR102144380B1 (ko) 제2형 당뇨병 치료를 위한 락토페린 기반의 유전자 전달체
JP2000502244A (ja) トキソプラズマ・ゴンディ糖複合体
EP2430151B1 (fr) Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6
WO2023127645A1 (ja) エクソソーム、それを形成するための方法、及びそれを含有する組成物
JP2666211B2 (ja) 抗体およびそれを有効成分とする齲蝕予防剤の製造方法
CA2016948A1 (en) Polysaccharide mixture with immune stimulating and anti-proliferating effect, method of production and medicines containing the substances
FR2682599A1 (fr) Procede pour l'obtention d'extraits parietaux de nocardia, purifies et non pyrogenes, utiles notamment comme reactifs de diagnostic en imagerie medicale.
Lohse et al. Pancreatic citrate and protein secretion of alcoholic dogs in response to graded doses of caerulein
KR20220019165A (ko) 간 섬유화 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
FZDE Dead